CCK‐JMV‐180 acts as an antagonist of the CCK<sub>A</sub> receptor in the human IMR‐32 neuroblastoma cell linePaul Schaeffer, Jean Marc Herbert, V. Prabonnaud et al.|FEBS Letters|1994Cited by 6
Characterisation of the effects of SR146131, a novel non-peptide CCK1 receptor agonist, on IMR-32 human neuroblastoma cellsPaul Schaeffer, Jean Marc Herbert, Albiñana Néstor et al.|European Journal of Pharmacology|2000Cited by 4
Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991))Bruce Ruggeri, Craig A. Dionne, J. B. Singh et al.|Cancer Research|2003Cited by 0